International Business Times
May 19, 2013
A 53-year-old British father has become the first man to have his prostate removed because tests revealed he was carrying a “faulty” cancer gene.
A clinical trial at London’s Institute of Cancer Research revealed that he carried the BRCA2 gene, which research shows is associated with a high risk of developing prostate cancer.
Several of the man’s family had suffered from breast or prostate cancer, which is why he took part in the study.
This article was posted: Sunday, May 19, 2013 at 9:56 am